LUCEMYRA is indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults
Manufacturer # 27505005036
Brand Lucemyra®
Manufacturer US Worldmeds
Country of Origin Unknown
Application Central Alpha 2-Adrenergic Agonist
Container Type Bottle
Dosage Form Tablet
Generic Drug Code 52540
Generic Drug Name Lofexidine HCl
Is_Active_Vendor Y
Is_DSCSA N
Is_Discontinued N
Is_Medical_Device Y
Lot_Tracking_Flag N
NDC Number 27505005036
On_Allocation N
Product Dating McKesson Acceptable Dating: we will ship >= 90 days
Quantity 36 Tablets
Strength 0.18 mg
Supplier_ID 3885243
UNSPSC Code 51392209
User Adults
